Risk factor analyses for macrovascular complication in nonobese NIDDM patients: Multiclinical study for diabetic macroangiopathy (MSDM)

Diabetes

Volumn 45, Issue 3 SUPPL., 1996, Pages

  Ito, Hideki ^a   Harano, Yutaka ^b   Suzuki, Masaaki ^b   Hattori, Yuichi ^c   Takeuchi, Makoto ^d   Inada, Hiroshi ^b   Inoue, Junichiro ^a   Kawamori, Ryuzo ^e   Murase, Toshio ^f   Ouchi, Yasuyoshi ^g   Umeda, Fumio ^h   Nawata, Hajime ^h   Orimo, Hajime ⁱ  

^a Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KONAN UNIVERSITY   (Japan)

^d KOBE CITY COLLEGE OF TECHNOLOGY   (Japan)

^e JUNTENDO UNIVERSITY   (Japan)

^f TORANOMON HOSPITAL   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h KYUSHU UNIVERSITY   (Japan)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL TRIAL; CONFERENCE PAPER; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

AGED; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOGEN; HUMANS; JAPAN; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 19244384444     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Haffner SM, Stern MP, Rewers M: Diabetes and atherosclerosis: epidemiological considerations. In Diabetes and Atherosclerosis: Molecular Basis and Clinical Aspects. Draznin B, Eckel R, Eds. New York, Elsevier, 1993, p. 229-254
2. Pyörälä K, Laakso M, Unsitupa M: Diabetes and atherosclerosis: an epidemiological view. Diabetes Metab Rev 3:463-524, 1987
3. Chait A, Bierman EL: Pathogenesis of macrovascular disease in diabetes. In Joslin's Diabetes Mellitus. 13th ed. Kahn CR, Weir GC, Eds. Philadelphia, Lea & Febiger, 1094, p. 648-664
4. Takeda R, Shimizu M: Ischemic heart disease in patients with diabetes mellitus in Japan. Diabetes Res Clin Pract 24 (Suppl.):S199-S203, 1994
5. Kameyama M, Fushimi H, Udaka F: Diabetes mellitus and cerebral vascular disease. Diabetes Res Clin Pract 24 (Suppl.):S205-S208, 1994
6. Donahue RP, Abbott RD, Reed DM, Yano K: Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry: Honolulu Heart Program. Diabetes 36:689-092, 1987
7. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 41:202-208, 1992
8. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 59:8-13, 1979
9. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: Diabetes, blood lipids and the role of obesity in coronary heart disease risk for women: The Framingham Study. Ann Intern Med 87:393-397, 1977
10. Standl E, Janka HU: High serum insulin concentrations in relation to other cardiovascular risks in macrovascular disease of type 2 diabetes. Horm Metab Res (Suppl. 15):46-51, 1985
11. Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW, Fujimoto WY: Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance. Diabetologia 33:489-496, 1990
12. Ronnemaa T, Laasko M, Pÿrälä K, Kallio V, Puukka P: High fasting plasma insulin is an indicator of coronary heart disease in non-insulin-dependent diabetic patients and nondiabetic subjects. Arterioscler Thromb 11:80-90, 1991